TCL Archive NCAB Okays Effort To Relax $5 Million Limit On Center Core Grants In Cancer Act Renewal November 19, 1976
TCL Archive FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March. January 21, 2005
TCL Archive Cancer Center To Get Recommended Funding, Restoration of 1990-91 Cuts, NCI Tells Directors July 24, 1992
TCL Archive FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin April 5, 1985
TCL Archive In Brief: Treatment Reorganization Will Give Rauscher “Lumps,” He Says; Coordinating Group Favored August 16, 1974
TCL Archive Drug Shortages Reach All-Time High—Ben Venue Exit Will Make Problem Worse October 11, 2013
